
Metabolex, Inc. is a pharmaceutical company dedicated to the discovery and development of drugs to treat diabetes and related metabolic disorders. The company had just raised over $44 Million in financing and had compounds in advanced stages of drug development. Metabolex wanted to transform the external view of the company from an academic and scientific leader to a company with a huge business opportunity.

